about us  synergy pharmaceuticals inc sgyp investors careers contact us about us home we live gi synergy pharmaceuticals is a biopharmaceutical company focused on the development and commercialization of novel gastrointestinal gi therapies we are committed to scientifically driven innovation providing novel treatment options for patients and healthcare providers rewarding opportunities for our employees and creating exceptional value for our shareholders we have pioneered discovery research and development efforts on analogs of uroguanylin a naturally occurring human gi peptide for the treatment of gi diseases and disorders  we discovered are developing and control  worldwide rights to our proprietary uroguanylin based gi platform that includes one commercial product trulance™ plecanatide and a second lead product candidate dolcanatide we are based in new york city with research technical operations and commercial offices in suburban philadelphia synergy sgyp became a public company in july  and is currently listed on nasdaq what matters to us at synergy our values guide every aspect of our business—from our relationships with customers to how we approach science and innovation and to realizing our vision of a healthier future for patients our pipeline we see gi differently at synergy pharmaceuticals we have a different perspective in gastrointestinal gi science with our novel approach we are redefining how gi conditions diseases and disorders are treated igniting change for new solutions at synergy we’re challenging the status quo in gi to develop new treatments that offer the potential to change people’s lives be the change in gi we see gi differently at synergy pharmaceuticals we have a different perspective in gastrointestinal gi science with our novel approach we are redefining how gi conditions diseases and disorders are treated innovation begins with uncovering insights we dig deeper to discover breakthrough solutions for unmet needs in the gi category uncover more we see gi differently at synergy pharmaceuticals we have a different perspective in gastrointestinal gi science with our novel approach we are redefining how gi conditions diseases and disorders are treated fighting for patients is at our core with our novel approach to gi science we are focused on the development of novel therapies that offer the potential to address patient needs learn more contact us synergy pharmaceuticals inc  lexington avenue suite  new york ny  phone   fax   infosynergypharmacom required field contact type  corporate investor relations transfer agent media first name last name email comments submit press releases  synergy pharmaceuticals inc sgyp investors careers contact us press releases home investors news press releases investors all news           synergy pharmaceuticals announces acceptance of supplemental new drug application snda for trulance™ plecanatide for the treatment of adults with irritable bowel syndrome with constipation ibsc published on jun   view press release synergy pharmaceuticals to present at the jefferies  global healthcare conference published on may   view press release synergy pharmaceuticals reports first quarter  financial results and business update published on may   view press release synergy pharmaceuticals to present positive trulance™ plecanatide phase  data at digestive disease week ddw for the treatment of irritable bowel syndrome with constipation ibsc published on may   view press release synergy presents new insights at digestive disease week ddw examining patient and physician perceptions and experiences with chronic idiopathic constipation cic published on may   view press release synergy pharmaceuticals to present trulance™ plecanatide phase  data at digestive disease week ddw for the treatment of adults with chronic idiopathic constipation cic with moderate to very severe bloating published on may   view press release synergy pharmaceuticals to highlight new data for trulance™ plecanatide at digestive disease week ddw published on may   view press release synergy pharmaceuticals to present at the nd annual deutsche bank healthcare conference published on apr   view press release synergy pharmaceuticals appoints gary g gemignani as chief financial officer published on apr   view press release synergy pharmaceuticals announces issuance of three new patents expected to extend trulance™ plecanatide patent protection until  published on apr   view press release            next » investor relations  synergy pharmaceuticals inc sgyp investors careers contact us investor relations home investors investor relations investors company overview synergy pharmaceuticals inc nasdaq sgyp synergy pharmaceuticals inc is a biopharmaceutical company focused on the development and commercialization of novel gastrointestinal gi therapies we are committed to scientifically driven innovation providing novel treatment options for patients and healthcare providers rewarding opportunities for our employees and creating exceptional value for our shareholders we have pioneered discovery research and development efforts on analogs of uroguanylin a naturally occurring human gi peptide for the treatment of gi diseases and disorders  we discovered are developing and control  worldwide rights to our proprietary uroguanylin based gi platform that includes one commercial product trulance™ plecanatide and a second lead product candidate dolcanatide we are based in new york city with research technical operations and commercial offices in suburban philadelphia synergy sgyp became a public company in july  and is currently listed on nasdaq stock information sgyp nasdaq volume market cap change day high day low view stock information press releases jun   synergy pharmaceuticals announces acceptance of supplemental new  view article may   synergy pharmaceuticals to present at the jefferies  view article may   synergy pharmaceuticals reports first quarter  financial  view article view all press releases events upcoming event synergy pharmaceuticals q  financial results aug   • pm edt archived event synergy pharmaceuticals  annual meeting jun   • am edt archived event jefferies  global healthcare conference jun   • pm edt webcast view all events press releases  synergy pharmaceuticals inc sgyp investors careers contact us press releases home investors news press releases investors all news           synergy pharmaceuticals announces acceptance of supplemental new drug application snda for trulance™ plecanatide for the treatment of adults with irritable bowel syndrome with constipation ibsc published on jun   view press release synergy pharmaceuticals to present at the jefferies  global healthcare conference published on may   view press release synergy pharmaceuticals reports first quarter  financial results and business update published on may   view press release synergy pharmaceuticals to present positive trulance™ plecanatide phase  data at digestive disease week ddw for the treatment of irritable bowel syndrome with constipation ibsc published on may   view press release synergy presents new insights at digestive disease week ddw examining patient and physician perceptions and experiences with chronic idiopathic constipation cic published on may   view press release synergy pharmaceuticals to present trulance™ plecanatide phase  data at digestive disease week ddw for the treatment of adults with chronic idiopathic constipation cic with moderate to very severe bloating published on may   view press release synergy pharmaceuticals to highlight new data for trulance™ plecanatide at digestive disease week ddw published on may   view press release synergy pharmaceuticals to present at the nd annual deutsche bank healthcare conference published on apr   view press release synergy pharmaceuticals appoints gary g gemignani as chief financial officer published on apr   view press release synergy pharmaceuticals announces issuance of three new patents expected to extend trulance™ plecanatide patent protection until  published on apr   view press release            next » synergy pharmaceuticals inc nasdaq sgyp  official site  synergy pharmaceuticals inc sgyp investors careers contact us at synergy we’re challenging the status quo in gastrointestinal gi medicine to develop new treatments that offer the potential to change people’s lives who we are now available trulance™ plecanatide please see full prescribing information including box warning at trulancecom learn more latest news press releases jun   synergy pharmaceuticals announces acceptance of supplemental new  view article may   synergy pharmaceuticals to present at the jefferies  view article view all press releases experienced leadership our leadership team has extensive clinical development and commercial experience in the biopharmaceutical industry and the gi category learn more investor relations  synergy pharmaceuticals inc sgyp investors careers contact us investor relations home investors investor relations investors company overview synergy pharmaceuticals inc nasdaq sgyp synergy pharmaceuticals inc is a biopharmaceutical company focused on the development and commercialization of novel gastrointestinal gi therapies we are committed to scientifically driven innovation providing novel treatment options for patients and healthcare providers rewarding opportunities for our employees and creating exceptional value for our shareholders we have pioneered discovery research and development efforts on analogs of uroguanylin a naturally occurring human gi peptide for the treatment of gi diseases and disorders  we discovered are developing and control  worldwide rights to our proprietary uroguanylin based gi platform that includes one commercial product trulance™ plecanatide and a second lead product candidate dolcanatide we are based in new york city with research technical operations and commercial offices in suburban philadelphia synergy sgyp became a public company in july  and is currently listed on nasdaq stock information sgyp nasdaq volume market cap change day high day low view stock information press releases jun   synergy pharmaceuticals announces acceptance of supplemental new  view article may   synergy pharmaceuticals to present at the jefferies  view article may   synergy pharmaceuticals reports first quarter  financial  view article view all press releases events upcoming event synergy pharmaceuticals q  financial results aug   • pm edt archived event synergy pharmaceuticals  annual meeting jun   • am edt archived event jefferies  global healthcare conference jun   • pm edt webcast view all events synergy pharmaceuticals inc nasdaq sgyp  official site  synergy pharmaceuticals inc sgyp investors careers contact us at synergy we’re challenging the status quo in gastrointestinal gi medicine to develop new treatments that offer the potential to change people’s lives who we are now available trulance™ plecanatide please see full prescribing information including box warning at trulancecom learn more latest news press releases jun   synergy pharmaceuticals announces acceptance of supplemental new  view article may   synergy pharmaceuticals to present at the jefferies  view article view all press releases experienced leadership our leadership team has extensive clinical development and commercial experience in the biopharmaceutical industry and the gi category learn more contact us  synergy pharmaceuticals inc sgyp investors careers contact us contact us home required field contact type  corporate investor relations transfer agent media first name last name email comments submit new york headquarters synergy pharmaceuticals inc  lexington avenue suite  new york ny  phone   fax   infosynergypharmacom careers  synergy pharmaceuticals inc sgyp investors careers contact us careers home careers current openings click here to apply for current sales opportunities there are currently no open positions please check back soon for new opportunities sgyp stock price  synergy pharmaceuticals inc stock quote us nasdaq  marketwatch sections watchlist signup • login search bulletin us europe asia fx rates futures range d d m m m y y dow    sp     nasdaq    globaldow    gold    oil    sp  movers algn  mhk  expe  col  fls  mo  gt  sbux  latest newsall times eastern p tempur sealy stock price target raised to  from  at cfra p fiat chrysler gets approval to sell diesel cars p updated starbucks’ teavana stores are the latest casualty at the mall p updated high times is going public through a deal with a blankcheck company — and here’s what that means p updated intel earnings have message for amd and nvidia ‘bring it on’ p updated foxconn’s history of broken promises casts a shadow on wisconsin news p updated tesla’s model  will be launched with panacheand a partylater friday p updated all the companies in jeff bezos’s empire in one large chart p baker hughes data show weekly us oilrig count up a third time this month p amazon’s postearnings stock selloff is the smallest in seven years to be replaced home investing quotes stocks united states sgyp overview compare quotes stock screener earnings calendar sectors nasdaq sgyp us nasdaq join td ameritrade find a broker synergy pharmaceuticals inc watchlist createsgypalert open last updated jul    pm edt real time quote     previous close  advanced charting d d m m m ytd y y all   vol advanced charting  vs avg volume m  day avg  m open  last   day lowhigh  day range   week lowhigh  your watchlist customize marketwatch have watchlists log in to see them here or sign up to get started create account … or log in symbol last chg chg  no items in watchlist there are currently no items in this watchlist add ticker to watchlist go to your watchlist no saved watchlists create a list of the investments you want to track create watchlist …or try this starter list uh oh something went wrong while loading watchlist go to watchlist recently viewed tickers no recent tickers visit a quote page and your recently viewed tickers will be displayed here search tickers overview profile news charts financials historical quotes analyst estimates options sec filings insiders key data open  day range     week range    market cap m shares outstanding m public float m beta  rev per employee k pe ratio na eps  yield na dividend na exdividend date na short interest m   of float shorted  average volume m performance  day   month   month  ytd   year  recent news marketwatch other dow jones synergy pharma stock sinks  after announcement of common stock offering feb   at  am et by emma court synergy pharma stock sinks  after announcement of common stock offering feb   at  am et by emma court synergy pharmaceuticals stock soars  premarket after positive trial results dec   at  am et by tomi kilgore synergy pharmaceuticals surges  in premarket trade on positive latestage clinical trial results dec   at  am et by emma court synergy pharma halted on latestage trial results dec   at  am et by emma court in focus bulls maintain their advantage apr   at  pm et by lawrence g mcmillan auditor warnings on large company solvency reach highest level since crisis apr   at  pm et by francine mckenna insiders are bullish about these stocks apr   at  pm et by meena krishnamsetty wednesday’s biggest gaining and declining stocks jan   at  pm et by polya lesova synergys constipation drug meets key goals jan   at  am et synergy pharma up  in premarket jan   at  am et by steve gelsi friday’s biggest gaining and declining stocks may   at  pm et by marketwatch synergy pharma down  in premarket trades may   at  am et by steve gelsi drug company’s new poop emojis make a splash apr   at  am et on the wall street journal stocks to watch bristolmyers procter  gamble ge jan   at  am et on the wall street journal paulson takes stake in starwood hotels  resorts aug   at  pm et on the wall street journal pharmalot pharmalittle as the weekend nears we’re catching up on novo oxycontin and lots more mar   at  am et on the wall street journal stocks to watch health management family dollar adtran apr   at  am et on the wall street journal stocks to watch zipcar synergy pharma magnum hunter jan   at  am et on the wall street journal stocks to watch linkedin dolby labs estee lauder may   at  am et on the wall street journal recent news other news press releases trellus management company llc buys uniti group inc shotspotter inc general electric co  trellus management company llc buys uniti group inc shotspotter inc general electric co sells jinkosolar holding co mazor robotics viasat inc jul   at  pm et on gurufocuscom why ironwoods iw is refluxing into a sea of red why ironwoods iw is refluxing into a sea of red jul   at  pm et on seeking alpha what to expect ahead of synergy pharmaceuticals inc sgyp q earnings oppenheimer’s take oppenheimer analyst derek archila sees some shortterm capital rocky waters for synergy pharmaceuticals inc nasdaqsgyp  jul   at  pm et on smarteranalyst allergan reports positive new data on irritable bowl drug allergan plc agn has announced positive data from a pooled analysis of two phase iii studies evaluating its marketed drug viberzi eluxadoline for treatment of adults suffering from irritable bowel syndrome with diarrhea ibsd jul   at  pm et on zackscom synergy pharmaceuticals inc sgyp trulance poses enticing longterm uptake second quarter earnings for the year are due sometime around midaugust from synergy pharmaceuticals inc  jul   at  pm et on smarteranalyst healthcare guru samuel isaly plays two key biotech stocks synergy pharmaceuticals inc sgpy gilead sciences inc gild sameul isaly founder of one of the world’s most wellknown healthcare funds has made two  jun   at  am et on smarteranalyst synergy pharmaceuticals inc’s sgyp cic drug set to stay in spotlight btig weighs in btig analyst tim chiang was out today with a research note on drug maker synergy pharmaceuticals inc  jun   at  pm et on smarteranalyst ironwoods future outlook and uncertainty ironwoods future outlook and uncertainty jun   at  pm et on seeking alpha great point partners llc buys concert pharmaceuticals inc rigel pharmaceuticals inc ptc  great point partners llc buys concert pharmaceuticals inc rigel pharmaceuticals inc ptc therapeutics inc sells enanta pharmaceuticals inc merrimack pharmaceuticals inc colucid pharmaceuticals inc jun   at  pm et on gurufocuscom why this billionaire just bought gilead sciences synergy and valeant stock jun   at  pm et on motley fool my biggest mistake sticking with gilead too long bret jensen my biggest mistake sticking with gilead too long bret jensen jun   at  am et on seeking alpha chipotle is a buy  cramers lightning round  chipotle is a buy  cramers lightning round  jun   at  am et on seeking alpha rodman  renshaw roots for synergy pharmaceuticals inc sgyp ahead of promising commercial trajectory for trulance last week synergy pharmaceuticals inc nasdaqsgyp excited investors with the news that its drug trulance  jun   at  am et on smarteranalyst biotech forum daily digest  spotlight on  oncology concern verastem biotech forum daily digest  spotlight on  oncology concern verastem jun   at  am et on seeking alpha fda accepts synergys marketing application for expanded use of trulance shares ahead  premarket fda accepts synergys marketing application for expanded use of trulance shares ahead  premarket jun   at  am et on seeking alpha synergy pharmaceuticals oh frabjous day synergy pharmaceuticals oh frabjous day jun   at  pm et on seeking alpha is ironwoods growth about to slow jun   at  am et on motley fool synergy pharmaceuticals inc sgyp weekly rx’s hit a new high btig analyst tim chiang weighs in on synergy pharmaceuticals inc nasdaqsgyp following recent data that showed strong growth  jun   at  pm et on smarteranalyst why synergy pharmaceuticals shares are popping  today jun   at  pm et on motley fool thoughts on synergy pharmas valuation as cantor initiates at overweight thoughts on synergy pharmas valuation as cantor initiates at overweight jun   at  am et on benzingacom asiapacific chronic idiopathic constipation drug market forecast  asiapacific chronic idiopathic constipation drug market forecast  jul   at  pm et on pr newswire  prf global chronic idiopathic constipation drug market forecast  global chronic idiopathic constipation drug market forecast  jul   at  pm et on pr newswire  prf north america chronic idiopathic constipation drug market forecast  north america chronic idiopathic constipation drug market forecast  jul   at  pm et on pr newswire  prf europe chronic idiopathic constipation drug market forecast  europe chronic idiopathic constipation drug market forecast  jul   at  pm et on pr newswire  prf breakfast technical briefing on drug makers stocks  synergy pharma novo nordisk pernix therapeutics and depomed breakfast technical briefing on drug makers stocks  synergy pharma novo nordisk pernix therapeutics and depomed jul   at  am et on pr newswire  prf synergy pharmaceuticals announces acceptance of supplemental new drug application snda for trulance™ plecanatide for the treatment of adults with irritable bowel syndrome with constipation ibsc synergy pharmaceuticals announces acceptance of supplemental new drug application snda for trulance™ plecanatide for the treatment of adults with irritable bowel syndrome with constipation ibsc jun   at  am et on businesswire  bzx todays research reports on stocks to watch synergy pharmaceuticals and bioscrip inc todays research reports on stocks to watch synergy pharmaceuticals and bioscrip inc jun   at  am et on accesswire synergy pharmaceuticals to present at the jefferies  global healthcare conference synergy pharmaceuticals to present at the jefferies  global healthcare conference may   at  am et on businesswire  bzx technical reports on drug makers stocks  synergy pharma novo nordisk apricus biosciences and sucampo pharma technical reports on drug makers stocks  synergy pharma novo nordisk apricus biosciences and sucampo pharma may   at  am et on pr newswire  prf synergy pharmaceuticals and durect corporation both sail higher on trader optimism synergy pharmaceuticals and durect corporation both sail higher on trader optimism may   at  am et on accesswire synergy pharmaceuticals to present positive trulance™ plecanatide phase  data at digestive disease week ddw for the treatment of irritable bowel syndrome with constipation ibsc synergy pharmaceuticals to present positive trulance™ plecanatide phase  data at digestive disease week ddw for the treatment of irritable bowel syndrome with constipation ibsc may   at  am et on businesswire  bzx synergy pharmaceuticals to present trulance™ plecanatide phase  data at digestive disease week ddw for the treatment of adults with chronic idiopathic constipation cic with moderate to very severe bloating synergy pharmaceuticals to present trulance™ plecanatide phase  data at digestive disease week ddw for the treatment of adults with chronic idiopathic constipation cic with moderate to very severe bloating may   at  am et on businesswire  bzx synergy presents new insights at digestive disease week ddw examining patient and physician perceptions and experiences with chronic idiopathic constipation cic synergy presents new insights at digestive disease week ddw examining patient and physician perceptions and experiences with chronic idiopathic constipation cic may   at  am et on businesswire  bzx synergy pharmaceuticals to highlight new data for trulance™ plecanatide at digestive disease week ddw synergy pharmaceuticals to highlight new data for trulance™ plecanatide at digestive disease week ddw may   at  am et on businesswire  bzx synergy pharmaceuticals to present at the nd annual deutsche bank healthcare conference apr   at  am et on businesswire  bzx rasna therapeutics names dr kunwar shailubhai as new ceo apr   at  pm et on businesswire  bzx synergy pharmaceuticals appoints gary g gemignani as chief financial officer apr   at  am et on businesswire  bzx synergy pharmaceuticals announces issuance of three new patents expected to extend trulance™ plecanatide patent protection until  apr   at  am et on businesswire  bzx synergy pharmaceuticals launches the poop troop the first emoji keyboard designed to support dialogue around chronic idiopathic constipation cic apr   at  am et on businesswire  bzx drug makers stocks under scanner  synergy pharma novo nordisk apricus biosciences and sucampo pharma apr   at  am et on pr newswire  prf synergy pharmaceuticals inc synergy pharmaceuticals inc is a biopharmaceutical company which focuses on the development and commercialization of novel gastrointestinal therapies its product includes plecanatide and dolcanatide the company was founded by kunwar shailubhai on november   and is headquartered in new york ny see full profile analyst ratings sell under hold over buy number of ratings  full ratings thoughts on synergy pharmas valuation as cantor initiates at overweight jun   at  am et on benzingacom what synergys new patents mean for its commercial prospects apr   at  am et on benzingacom benzingas top upgrades downgrades for april   apr   at  am et on benzingacom competitors name chg  market cap progenics pharmaceuticals inc  m shire plc adr  b sucampo pharmaceuticals inc cl a  m ironwood pharmaceuticals inc cl a  b evoke pharma inc  m competitor data provided by partner content trending tickers powered by aks  sbux  dvax  x  bidu  advanced search stocks columns authors topics no results found video center learn morestoryful a division of news corp which owns marketwatch is a leading social media services company headquartered in dublin ireland storyful combines world class journalism with industryleading technology to discover verify and acquire original content and provide the ontheground sources news and media organizations need to tell the stories that matter to their audience stocks index  markets index bulletin investor alert new york markets close in market snapshot winners and losers stocks rates funds bonds benchmarks real estate investment trusts futures american depository receipt stocks exchange traded notes warrants indexes exchange traded funds currencies crypto currencies browse stocks stocks az abcdefghijklmnopqrstuvwxyzother browse by location argentina australia austria bahamas bahrain belgium bermuda botswana brazil british virgin islands canada cayman islands chile china colombia curacao cyprus czech republic denmark egypt estonia finland france germany gibraltar greece hong kong hungary iceland india indonesia ireland isle of man israel italy japan jordan kazakhstan kuwait latvia lebanon liechtenstein lithuania luxembourg malaysia malta mauritius mexico monaco money rates morocco namibia netherlands new zealand norway oman pakistan panama peru philippines poland portugal qatar romania russia saudi arabia singapore slovakia slovenia south africa south korea spain sri lanka sweden switzerland taiwan thailand tunisia turkey ukraine united arab emirates united states venezuela western samoa log in  pm edt july   marketstatecountryus new york open marketstatecountryuk london closed marketstatecountryjp tokyo closed marketstatecountryus   marketstatecountryuk   marketstatecountryjp   view all latest news newslatest ptempur sealy stock price target raised to  from  at cfra pfiat chrysler gets approval to sell diesel cars pstarbucks’ teavana stores are the latest casualty at the mall phigh times is going public through a deal with a blankcheck company — and here’s what that means pintel earnings have message for amd and nvidia ‘bring it on’ pfoxconn’s history of broken promises casts a shadow on wisconsin news ptesla’s model  will be launched with panacheand a partylater friday pall the companies in jeff bezos’s empire in one large chart pbaker hughes data show weekly us oilrig count up a third time this month pamazon’s postearnings stock selloff is the smallest in seven years peuropean stocks end at month low as ubs falls tech worries weigh psurging australian dollar makes life tough for central bankers pus weekly active oilrig count up  at  baker hughes pus total weekly active drillingrig count up  at  baker hughes pseptember wti oil trades at bbl little changed from before the rig data pwhy the sec’s crackdown could be good for initial coin offerings pmattel shares down  in friday trading pexpedia stock price target raised to  from  at ubs paarons shares up  in friday trading pwhere healthcare reform goes after failure to repeal and replace obamacare loading more headlines dow quoteszigmanrealtime    nasdaq quoteszigmanrealtime    sp  quoteszigmanrealtime    kiosk   the retirementors retirement advice from our industry experts our team of financial professionals can help you plan and save for retirement then live well in it congakioskretirementorshtml    alerts congakioskalertshtml    virtual stock exchange our free stockmarket game • trade your virtual portfolio in real time • talk strategies in group discussions • find or create a game that suits you • use our learning center to improve congakioskgameshtml    location scouts housingmarket insights from our realty pros plus the latest data from realtorcom on  home markets across the us • see our complete real estate site congakioskrealestatehtml    lazy portfolios set it and forget it check out the returns on our  lazy portfolios that are made up of lowcost buyandhold index funds • how to create your own lazy portfolio congakiosklazyportfoliohtml  marketwatchcom site index topics help feedback newsroom roster media archive premium products mobile company info code of conduct corrections advertising media kit advertise locally reprints  licensing broker center your ad choices follow marketwatch rss podcasts wsjcom barrons online bigcharts virtual stock exchange financial news london wsjcom small business realtorcom mansion global copyright   marketwatch inc all rights reserved by using this site you agree to the terms of service privacy policy and cookie policy intraday data provided by six financial information and subject to terms of use historical and current endofday data provided by six financial information all quotes are in local exchange time realtime last sale data for us stock quotes reflect trades reported through nasdaq only intraday data delayed at least  minutes or per exchange requirements marketwatch top stories link to marketwatchs slice  stocks index  markets index bulletin investor alert new york markets close in market snapshot winners and losers stocks rates funds bonds benchmarks real estate investment trusts futures american depository receipt stocks exchange traded notes warrants indexes exchange traded funds currencies crypto currencies browse stocks stocks az abcdefghijklmnopqrstuvwxyzother browse by location argentina australia austria bahamas bahrain belgium bermuda botswana brazil british virgin islands canada cayman islands chile china colombia curacao cyprus czech republic denmark egypt estonia finland france germany gibraltar greece hong kong hungary iceland india indonesia ireland isle of man israel italy japan jordan kazakhstan kuwait latvia lebanon liechtenstein lithuania luxembourg malaysia malta mauritius mexico monaco money rates morocco namibia netherlands new zealand norway oman pakistan panama peru philippines poland portugal qatar romania russia saudi arabia singapore slovakia slovenia south africa south korea spain sri lanka sweden switzerland taiwan thailand tunisia turkey ukraine united arab emirates united states venezuela western samoa log in  pm edt july   marketstatecountryus new york open marketstatecountryuk london closed marketstatecountryjp tokyo closed marketstatecountryus   marketstatecountryuk   marketstatecountryjp   view all latest news newslatest ptempur sealy stock price target raised to  from  at cfra pfiat chrysler gets approval to sell diesel cars pstarbucks’ teavana stores are the latest casualty at the mall phigh times is going public through a deal with a blankcheck company — and here’s what that means pintel earnings have message for amd and nvidia ‘bring it on’ pfoxconn’s history of broken promises casts a shadow on wisconsin news ptesla’s model  will be launched with panacheand a partylater friday pall the companies in jeff bezos’s empire in one large chart pbaker hughes data show weekly us oilrig count up a third time this month pamazon’s postearnings stock selloff is the smallest in seven years peuropean stocks end at month low as ubs falls tech worries weigh psurging australian dollar makes life tough for central bankers pus weekly active oilrig count up  at  baker hughes pus total weekly active drillingrig count up  at  baker hughes pseptember wti oil trades at bbl little changed from before the rig data pwhy the sec’s crackdown could be good for initial coin offerings pmattel shares down  in friday trading pexpedia stock price target raised to  from  at ubs paarons shares up  in friday trading pwhere healthcare reform goes after failure to repeal and replace obamacare loading more headlines dow quoteszigmanrealtime    nasdaq quoteszigmanrealtime    sp  quoteszigmanrealtime    kiosk   the retirementors retirement advice from our industry experts our team of financial professionals can help you plan and save for retirement then live well in it congakioskretirementorshtml    alerts congakioskalertshtml    virtual stock exchange our free stockmarket game • trade your virtual portfolio in real time • talk strategies in group discussions • find or create a game that suits you • use our learning center to improve congakioskgameshtml    location scouts housingmarket insights from our realty pros plus the latest data from realtorcom on  home markets across the us • see our complete real estate site congakioskrealestatehtml    lazy portfolios set it and forget it check out the returns on our  lazy portfolios that are made up of lowcost buyandhold index funds • how to create your own lazy portfolio congakiosklazyportfoliohtml  marketwatchcom site index topics help feedback newsroom roster media archive premium products mobile company info code of conduct corrections advertising media kit advertise locally reprints  licensing broker center your ad choices follow marketwatch rss podcasts wsjcom barrons online bigcharts virtual stock exchange financial news london wsjcom small business realtorcom mansion global copyright   marketwatch inc all rights reserved by using this site you agree to the terms of service privacy policy and cookie policy intraday data provided by six financial information and subject to terms of use historical and current endofday data provided by six financial information all quotes are in local exchange time realtime last sale data for us stock quotes reflect trades reported through nasdaq only intraday data delayed at least  minutes or per exchange requirements marketwatch top stories link to marketwatchs slice    sgyp stock price  synergy pharmaceuticals inc stock quote us nasdaq  marketwatch sections watchlist signup • login search bulletin us europe asia fx rates futures range d d m m m y y dow    sp     nasdaq    globaldow    gold    oil    sp  movers algn  mhk  expe  col  fls  mo  gt  sbux  latest newsall times eastern p tempur sealy stock price target raised to  from  at cfra p fiat chrysler gets approval to sell diesel cars p updated starbucks’ teavana stores are the latest casualty at the mall p updated high times is going public through a deal with a blankcheck company — and here’s what that means p updated intel earnings have message for amd and nvidia ‘bring it on’ p updated foxconn’s history of broken promises casts a shadow on wisconsin news p updated tesla’s model  will be launched with panacheand a partylater friday p updated all the companies in jeff bezos’s empire in one large chart p baker hughes data show weekly us oilrig count up a third time this month p amazon’s postearnings stock selloff is the smallest in seven years to be replaced home investing quotes stocks united states sgyp overview compare quotes stock screener earnings calendar sectors nasdaq sgyp us nasdaq join td ameritrade find a broker synergy pharmaceuticals inc watchlist createsgypalert open last updated jul    pm edt real time quote     previous close  advanced charting d d m m m ytd y y all   vol advanced charting  vs avg volume m  day avg  m open  last   day lowhigh  day range   week lowhigh  your watchlist customize marketwatch have watchlists log in to see them here or sign up to get started create account … or log in symbol last chg chg  no items in watchlist there are currently no items in this watchlist add ticker to watchlist go to your watchlist no saved watchlists create a list of the investments you want to track create watchlist …or try this starter list uh oh something went wrong while loading watchlist go to watchlist recently viewed tickers no recent tickers visit a quote page and your recently viewed tickers will be displayed here search tickers overview profile news charts financials historical quotes analyst estimates options sec filings insiders key data open  day range     week range    market cap m shares outstanding m public float m beta  rev per employee k pe ratio na eps  yield na dividend na exdividend date na short interest m   of float shorted  average volume m performance  day   month   month  ytd   year  recent news marketwatch other dow jones synergy pharma stock sinks  after announcement of common stock offering feb   at  am et by emma court synergy pharma stock sinks  after announcement of common stock offering feb   at  am et by emma court synergy pharmaceuticals stock soars  premarket after positive trial results dec   at  am et by tomi kilgore synergy pharmaceuticals surges  in premarket trade on positive latestage clinical trial results dec   at  am et by emma court synergy pharma halted on latestage trial results dec   at  am et by emma court in focus bulls maintain their advantage apr   at  pm et by lawrence g mcmillan auditor warnings on large company solvency reach highest level since crisis apr   at  pm et by francine mckenna insiders are bullish about these stocks apr   at  pm et by meena krishnamsetty wednesday’s biggest gaining and declining stocks jan   at  pm et by polya lesova synergys constipation drug meets key goals jan   at  am et synergy pharma up  in premarket jan   at  am et by steve gelsi friday’s biggest gaining and declining stocks may   at  pm et by marketwatch synergy pharma down  in premarket trades may   at  am et by steve gelsi drug company’s new poop emojis make a splash apr   at  am et on the wall street journal stocks to watch bristolmyers procter  gamble ge jan   at  am et on the wall street journal paulson takes stake in starwood hotels  resorts aug   at  pm et on the wall street journal pharmalot pharmalittle as the weekend nears we’re catching up on novo oxycontin and lots more mar   at  am et on the wall street journal stocks to watch health management family dollar adtran apr   at  am et on the wall street journal stocks to watch zipcar synergy pharma magnum hunter jan   at  am et on the wall street journal stocks to watch linkedin dolby labs estee lauder may   at  am et on the wall street journal recent news other news press releases trellus management company llc buys uniti group inc shotspotter inc general electric co  trellus management company llc buys uniti group inc shotspotter inc general electric co sells jinkosolar holding co mazor robotics viasat inc jul   at  pm et on gurufocuscom why ironwoods iw is refluxing into a sea of red why ironwoods iw is refluxing into a sea of red jul   at  pm et on seeking alpha what to expect ahead of synergy pharmaceuticals inc sgyp q earnings oppenheimer’s take oppenheimer analyst derek archila sees some shortterm capital rocky waters for synergy pharmaceuticals inc nasdaqsgyp  jul   at  pm et on smarteranalyst allergan reports positive new data on irritable bowl drug allergan plc agn has announced positive data from a pooled analysis of two phase iii studies evaluating its marketed drug viberzi eluxadoline for treatment of adults suffering from irritable bowel syndrome with diarrhea ibsd jul   at  pm et on zackscom synergy pharmaceuticals inc sgyp trulance poses enticing longterm uptake second quarter earnings for the year are due sometime around midaugust from synergy pharmaceuticals inc  jul   at  pm et on smarteranalyst healthcare guru samuel isaly plays two key biotech stocks synergy pharmaceuticals inc sgpy gilead sciences inc gild sameul isaly founder of one of the world’s most wellknown healthcare funds has made two  jun   at  am et on smarteranalyst synergy pharmaceuticals inc’s sgyp cic drug set to stay in spotlight btig weighs in btig analyst tim chiang was out today with a research note on drug maker synergy pharmaceuticals inc  jun   at  pm et on smarteranalyst ironwoods future outlook and uncertainty ironwoods future outlook and uncertainty jun   at  pm et on seeking alpha great point partners llc buys concert pharmaceuticals inc rigel pharmaceuticals inc ptc  great point partners llc buys concert pharmaceuticals inc rigel pharmaceuticals inc ptc therapeutics inc sells enanta pharmaceuticals inc merrimack pharmaceuticals inc colucid pharmaceuticals inc jun   at  pm et on gurufocuscom why this billionaire just bought gilead sciences synergy and valeant stock jun   at  pm et on motley fool my biggest mistake sticking with gilead too long bret jensen my biggest mistake sticking with gilead too long bret jensen jun   at  am et on seeking alpha chipotle is a buy  cramers lightning round  chipotle is a buy  cramers lightning round  jun   at  am et on seeking alpha rodman  renshaw roots for synergy pharmaceuticals inc sgyp ahead of promising commercial trajectory for trulance last week synergy pharmaceuticals inc nasdaqsgyp excited investors with the news that its drug trulance  jun   at  am et on smarteranalyst biotech forum daily digest  spotlight on  oncology concern verastem biotech forum daily digest  spotlight on  oncology concern verastem jun   at  am et on seeking alpha fda accepts synergys marketing application for expanded use of trulance shares ahead  premarket fda accepts synergys marketing application for expanded use of trulance shares ahead  premarket jun   at  am et on seeking alpha synergy pharmaceuticals oh frabjous day synergy pharmaceuticals oh frabjous day jun   at  pm et on seeking alpha is ironwoods growth about to slow jun   at  am et on motley fool synergy pharmaceuticals inc sgyp weekly rx’s hit a new high btig analyst tim chiang weighs in on synergy pharmaceuticals inc nasdaqsgyp following recent data that showed strong growth  jun   at  pm et on smarteranalyst why synergy pharmaceuticals shares are popping  today jun   at  pm et on motley fool thoughts on synergy pharmas valuation as cantor initiates at overweight thoughts on synergy pharmas valuation as cantor initiates at overweight jun   at  am et on benzingacom asiapacific chronic idiopathic constipation drug market forecast  asiapacific chronic idiopathic constipation drug market forecast  jul   at  pm et on pr newswire  prf global chronic idiopathic constipation drug market forecast  global chronic idiopathic constipation drug market forecast  jul   at  pm et on pr newswire  prf north america chronic idiopathic constipation drug market forecast  north america chronic idiopathic constipation drug market forecast  jul   at  pm et on pr newswire  prf europe chronic idiopathic constipation drug market forecast  europe chronic idiopathic constipation drug market forecast  jul   at  pm et on pr newswire  prf breakfast technical briefing on drug makers stocks  synergy pharma novo nordisk pernix therapeutics and depomed breakfast technical briefing on drug makers stocks  synergy pharma novo nordisk pernix therapeutics and depomed jul   at  am et on pr newswire  prf synergy pharmaceuticals announces acceptance of supplemental new drug application snda for trulance™ plecanatide for the treatment of adults with irritable bowel syndrome with constipation ibsc synergy pharmaceuticals announces acceptance of supplemental new drug application snda for trulance™ plecanatide for the treatment of adults with irritable bowel syndrome with constipation ibsc jun   at  am et on businesswire  bzx todays research reports on stocks to watch synergy pharmaceuticals and bioscrip inc todays research reports on stocks to watch synergy pharmaceuticals and bioscrip inc jun   at  am et on accesswire synergy pharmaceuticals to present at the jefferies  global healthcare conference synergy pharmaceuticals to present at the jefferies  global healthcare conference may   at  am et on businesswire  bzx technical reports on drug makers stocks  synergy pharma novo nordisk apricus biosciences and sucampo pharma technical reports on drug makers stocks  synergy pharma novo nordisk apricus biosciences and sucampo pharma may   at  am et on pr newswire  prf synergy pharmaceuticals and durect corporation both sail higher on trader optimism synergy pharmaceuticals and durect corporation both sail higher on trader optimism may   at  am et on accesswire synergy pharmaceuticals to present positive trulance™ plecanatide phase  data at digestive disease week ddw for the treatment of irritable bowel syndrome with constipation ibsc synergy pharmaceuticals to present positive trulance™ plecanatide phase  data at digestive disease week ddw for the treatment of irritable bowel syndrome with constipation ibsc may   at  am et on businesswire  bzx synergy pharmaceuticals to present trulance™ plecanatide phase  data at digestive disease week ddw for the treatment of adults with chronic idiopathic constipation cic with moderate to very severe bloating synergy pharmaceuticals to present trulance™ plecanatide phase  data at digestive disease week ddw for the treatment of adults with chronic idiopathic constipation cic with moderate to very severe bloating may   at  am et on businesswire  bzx synergy presents new insights at digestive disease week ddw examining patient and physician perceptions and experiences with chronic idiopathic constipation cic synergy presents new insights at digestive disease week ddw examining patient and physician perceptions and experiences with chronic idiopathic constipation cic may   at  am et on businesswire  bzx synergy pharmaceuticals to highlight new data for trulance™ plecanatide at digestive disease week ddw synergy pharmaceuticals to highlight new data for trulance™ plecanatide at digestive disease week ddw may   at  am et on businesswire  bzx synergy pharmaceuticals to present at the nd annual deutsche bank healthcare conference apr   at  am et on businesswire  bzx rasna therapeutics names dr kunwar shailubhai as new ceo apr   at  pm et on businesswire  bzx synergy pharmaceuticals appoints gary g gemignani as chief financial officer apr   at  am et on businesswire  bzx synergy pharmaceuticals announces issuance of three new patents expected to extend trulance™ plecanatide patent protection until  apr   at  am et on businesswire  bzx synergy pharmaceuticals launches the poop troop the first emoji keyboard designed to support dialogue around chronic idiopathic constipation cic apr   at  am et on businesswire  bzx drug makers stocks under scanner  synergy pharma novo nordisk apricus biosciences and sucampo pharma apr   at  am et on pr newswire  prf synergy pharmaceuticals inc synergy pharmaceuticals inc is a biopharmaceutical company which focuses on the development and commercialization of novel gastrointestinal therapies its product includes plecanatide and dolcanatide the company was founded by kunwar shailubhai on november   and is headquartered in new york ny see full profile analyst ratings sell under hold over buy number of ratings  full ratings thoughts on synergy pharmas valuation as cantor initiates at overweight jun   at  am et on benzingacom what synergys new patents mean for its commercial prospects apr   at  am et on benzingacom benzingas top upgrades downgrades for april   apr   at  am et on benzingacom competitors name chg  market cap progenics pharmaceuticals inc  m shire plc adr  b sucampo pharmaceuticals inc cl a  m ironwood pharmaceuticals inc cl a  b evoke pharma inc  m competitor data provided by partner content trending tickers powered by aks  sbux  dvax  x  bidu  advanced search stocks columns authors topics no results found video center learn morestoryful a division of news corp which owns marketwatch is a leading social media services company headquartered in dublin ireland storyful combines world class journalism with industryleading technology to discover verify and acquire original content and provide the ontheground sources news and media organizations need to tell the stories that matter to their audience sgyp  stock quote for synergy pharmaceuticals inc  msn money msn back to msn home money web search sign in change language  content américa latina español argentina español australia english belgië nederlands belgique français brasil português canada english canada français chile español colombia español danmark dansk deutschland deutsch españa español france français india english indonesia bahasa indonesia ireland english italia italiano malaysia english méxico español nederland nederlands new zealand english norge norsk bokmål österreich deutsch perú español philippines english polska polski portugal português schweiz deutsch singapore english south africa english suisse français suomi suomi sverige svenska türkiye türkçe united arab emirates english united kingdom english united states english united states español venezuela español việt nam tiếng việt ελλάδα ελληνικά россия pусский ישראל עברית‏ الإمارات العربية المتحدة العربية‏ المملكة العربية السعودية العربية‏ مصر العربية‏ ไทย ไทย 한국 한국어      語   switch to latino español feedback help adchoices synergy pharmaceuticals inc nasdaq sgyp us markets open adchoices     after hours     july    pm edt bats bzx realtime last price currency in usd save summary financials analysis options ownership company history related open  previous close  volume avg m m days range  wk range  market cap m dividend rate  yield  beta  shares outstanding m pe ratio eps  recent news the  most shorted nasdaq stocks  wall st  stocks moving in thursdays premarket session benzinga the  most shorted nasdaq stocks  wall st allergan reports positive new data on irritable bowl drug zacks equity research benzingas option alert recap from june  benzinga the  most shorted nasdaq stocks  wall st why this billionaire just bought gilead sciences synergy and valeant stock the motley fool go inside amazons disruptive deal for whole foods cramers mad money recap friday  the street cramers lightning round heres why you should buy shares of chipotle cnbc the  most shorted nasdaq stocks  wall st is ironwoods growth about to slow the motley fool why synergy pharmaceuticals shares are popping  today the motley fool  biggest midday gainers for friday benzinga midday market update crude oil down  synergy pharma shares spike higher benzinga jim cramer  canada goose and workday are killing it and critics have now stopped laughing the street greenlights david einhorn still thinks tesla reminds him of the march  internet bubble the street house to vote on doddfrank reforms next week the street biotech movers synergy pharmaceuticals explodes  and bluebird bio may be next the street midmorning market update markets edge hogher lululemon beats q estimates benzinga  stocks moving in fridays premarket session benzinga with ardelyxs fall does synergy now have a clear path to victory the motley fool adchoices adchoices adchoices markets dow dow ▼    last updated time   pm edt markets nasdaq nasdaq ▼    ftse  ftse  ▼    nyse composite nyse composite ▼    adchoices feedback send feedback provide feedback report a problem we appreciate your input select a category im having problems with top destinations im having issues searching im having problems with featured apps i see an error in the content other how we can improve please give an overall site rating submit close privacy statement help help  support stockscountryunited states index  markets index bulletin investor alert new york markets close in market snapshot winners and losers stocks rates funds bonds benchmarks real estate investment trusts futures american depository receipt stocks exchange traded notes warrants indexes exchange traded funds currencies crypto currencies location united states name exchange sector  communique laboratory inc ocqlf ootc software  property insurance holdings inc pih xnas nonlife insurance flowerscom inc cl a flws xnas specialty retail pm industries inc opmz ootc food products st capital bank ca fisb ootc banking st constitution bancorp fccy xnas banking st nrg corp fnrc ootc oil extraction st source corp srce xnas banking  motors inc etfm ootc automobiles st century fox inc cl a foxa xnas broadcasting st century fox inc cl b fox xnas broadcasting vianet group inc adr vnet xnas internetonline nd century group inc xxii xase biotechnology  kid doc inc tvmd ootc healthcare provision u inc twou xnas software xleveraged long etracs linked to wells fargo business development co index  bdcl arcx major international banks xleveraged long etracs wells fargo business development lbdc arcx major international banks d eye solutions inc tdey ootc motion picturesound recording d pioneer systems inc dpsm ootc software d systems corp ddd xnys computersconsumer electronics dicon corp tdcp ootc software dshoppingcom thds ootc mixed retailing dx industries inc dddx ootc computersconsumer electronics i group plc adr tgopy ootc finance companies m co mmm xnys diversified holding companies pea international inc tpnl xotc accounting power energy group inc pspw ootc renewable energy generation tl technologies corp ttmzf ootc advertisingmarketingpublic relations  property management inc ftpm ootc real estate agentsbrokers cable tv international inc catv ootc diversified business services licensing corp fourq ootc diversified business services com ltd adr wbai xnys gambling industries job inc adr jobs xnas employmenttraining services com inc adr wuba xnys consumer services barz international inc barz ootc networking n plus inc fplsf ootc commodity chemicals d global technologies inc sixd ootc computer services  renewable energy corp rnwr ootc multiutilities  energy ltd adr tngry ootc oil extraction  holdings plc eihdf ootc gambling industries point energy partners lp cafd xnas renewable energy generation x inc eght xnas wired telecommunications services a clean slate inc drwn ootc diversified business services aw revenue royalties income fund awrrf ootc restaurants a h belo corp series a ahc xnys publishing a schulman inc shlm xnas commodity chemicals a schulman inc  pfd slmnp ootc commodity chemicals ad makepeace co make ootc farming am castle  co cas xnys wholesalers ao smith corp aos xnys building materialsproducts ap moellermaersk as adr amkby ootc water transportshipping ap moellermaersk as series a amkaf ootc water transportshipping ap moellermaersk as series b amkbf ootc water transportshipping as roma spa asraf ootc recreational services a group inc awon ootc tobacco a networks inc aten xnys computer services a milk co ltd acopf ootc biotechnology aac holdings inc aac xnys healthcare provision aac technologies holdings inc aacaf ootc industrial electronics aac technologies holdings inc adr aacay ootc industrial electronics aaon inc aaon xnas building materialsproducts aap inc aapj ootc food products aar corp air xnys aerospace productsparts aarons inc aan xnys consumer services ab science sa abscf ootc pharmaceuticals ab svensk exportkredit elements linked to mlcx biofuels index total return fue arcx finance companies ab svensk exportkredit elements linked to mlcx grain index total return gru arcx finance companies abt financial corp abto ootc banking abacus mining  exploration corp abcff ootc general mining abakan inc abki ootc industrial products abattis bioceuticals corp attbf ootc biotechnology abaxis inc abax xnas medical equipmentsupplies abb ltd ablzf ootc industrial machinery abb ltd adr abb xnys industrial machinery abbott laboratories abt xnys pharmaceuticals abbvie inc abbv xnys biotechnology abby inc abby ootc oil extraction abcam plc abczf ootc biotechnology abcam plc adr abczy ootc biotechnology abco energy inc abce ootc industrial machinery abcourt mines inc abmbf ootc general mining aben resources ltd abnaf ootc general mining abengoa sa b agoaf ootc construction abeona therapeutics inc abeo xnas biotechnology abeona therapeutics inc wt abeow xnas abercrombie  fitch co anf xnys clothing retail aberdeen asiapacific income fund inc fax xase closedend funds aberdeen asiapacific income investment co ltd abakf ootc closedend funds aberdeen asset management plc abdnf ootc investment advisors aberdeen asset management plc adr abdny ootc investment advisors aberdeen australia equity fund inc iaf xase closedend funds aberdeen chile fund inc ch xase closedend funds aberdeen emerging markets smaller company opportunities fund inc abe xase closedend funds aberdeen global income fund inc fco xase closedend funds aberdeen greater china fund inc gch xnys closedend funds aberdeen indonesia fund inc if xase closedend funds aberdeen international inc aabvf ootc general mining aberdeen israel fund inc isl xase closedend funds aberdeen japan equity fund inc jeq xnys closedend funds aberdeen latin america equity fund inc laq xase closedend funds aberdeen singapore fund inc sgf xnys closedend funds abertis infraestructuras sa adr abrty ootc transportation services ability inc abil xnas precision products ability inc wt abiwf ootc abiomed inc abmd xnas medical equipmentsupplies abitibi royalties inc atbyf ootc general mining able energy inc able ootc gas utilities ablynx nv ablyf ootc biotechnology abm industries inc abm xnys diversified business services abraxas petroleum corp axas xnas oil extraction absecon bancorp ascn ootc banking absolute health  fitness inc ahfi ootc recreational services absolute software corp alswf ootc software abt holdings inc abot ootc precious metals abtech holdings inc abhd ootc industrial machinery abv consulting inc abvn ootc advertisingmarketingpublic relations ac immune sa aciu xnas biotechnology acacia communications inc acia xnas networking acacia diversified holdings inc acca ootc specialty retail acacia mining plc abglf ootc gold acacia research corp  acacia technologies actg xnas diversified business services acadia healthcare co inc achc xnas healthcare provision acadia pharmaceuticals inc acad xnas biotechnology acadia realty trust akr xnys acadian timber corp acazf ootc forestry  wood products acasti pharma inc acst xnas pharmaceuticals accelera innovations inc acnv ootc healthcare provision accelerate diagnostics inc axdx xnas biotechnology accelerize inc aclz xotc life insurance acceleron pharma inc xlrn xnas biotechnology accenture plc cl a acn xnys diversified business services access national corp ancx xnas banking access power inc accr ootc wired telecommunications services access worldwide communications inc awwc ootc advertisingmarketingpublic relations acciona sa acxif ootc construction acco brands corp acco xnys nondurable household products accor sa acrff ootc hotels accor sa adr accyy ootc hotels accordia golf co ltd acgff ootc recreational services accredited mortgage loan reit trust  perp cum pfd series a ahhap ootc mortgages accretive health inc achi ootc healthcare provision accuray inc aray xnas medical equipmentsupplies accuride corp acw xnys auto  commercial vehicle parts acelrx pharmaceuticals inc acrx xnas pharmaceuticals acer inc gdr reg s aceyy ootc computersconsumer electronics acerus pharmaceuticals corp trlpf ootc biotechnology aceto corp acet xnas specialty chemicals achaogen inc akao xnas biotechnology achillion pharmaceuticals inc achn xnas biotechnology aci worldwide inc aciw xnas software «» log in  pm edt july   marketstatecountryus new york open marketstatecountryuk london closed marketstatecountryjp tokyo closed marketstatecountryus   marketstatecountryuk   marketstatecountryjp   view all latest news newslatest ptempur sealy stock price target raised to  from  at cfra pfiat chrysler gets approval to sell diesel cars pstarbucks’ teavana stores are the latest casualty at the mall phigh times is going public through a deal with a blankcheck company — and here’s what that means pintel earnings have message for amd and nvidia ‘bring it on’ pfoxconn’s history of broken promises casts a shadow on wisconsin news ptesla’s model  will be launched with panacheand a partylater friday pall the companies in jeff bezos’s empire in one large chart pbaker hughes data show weekly us oilrig count up a third time this month pamazon’s postearnings stock selloff is the smallest in seven years peuropean stocks end at month low as ubs falls tech worries weigh psurging australian dollar makes life tough for central bankers pus weekly active oilrig count up  at  baker hughes pus total weekly active drillingrig count up  at  baker hughes pseptember wti oil trades at bbl little changed from before the rig data pwhy the sec’s crackdown could be good for initial coin offerings pmattel shares down  in friday trading pexpedia stock price target raised to  from  at ubs paarons shares up  in friday trading pwhere healthcare reform goes after failure to repeal and replace obamacare loading more headlines dow quoteszigmanrealtime    nasdaq quoteszigmanrealtime    sp  quoteszigmanrealtime    kiosk   the retirementors retirement advice from our industry experts our team of financial professionals can help you plan and save for retirement then live well in it congakioskretirementorshtml    alerts congakioskalertshtml    virtual stock exchange our free stockmarket game • trade your virtual portfolio in real time • talk strategies in group discussions • find or create a game that suits you • use our learning center to improve congakioskgameshtml    location scouts housingmarket insights from our realty pros plus the latest data from realtorcom on  home markets across the us • see our complete real estate site congakioskrealestatehtml    lazy portfolios set it and forget it check out the returns on our  lazy portfolios that are made up of lowcost buyandhold index funds • how to create your own lazy portfolio congakiosklazyportfoliohtml  marketwatchcom site index topics help feedback newsroom roster media archive premium products mobile company info code of conduct corrections advertising media kit advertise locally reprints  licensing broker center your ad choices follow marketwatch rss podcasts wsjcom barrons online bigcharts virtual stock exchange financial news london wsjcom small business realtorcom mansion global copyright   marketwatch inc all rights reserved by using this site you agree to the terms of service privacy policy and cookie policy intraday data provided by six financial information and subject to terms of use historical and current endofday data provided by six financial information all quotes are in local exchange time realtime last sale data for us stock quotes reflect trades reported through nasdaq only intraday data delayed at least  minutes or per exchange requirements marketwatch top stories link to marketwatchs slice  sgyp key statistics  synergy pharmaceuticals inc financial ratios  marketwatch bulletin investor alert new york markets close in market snapshot winners and losers expand keep open close expand keep open close expand keep open close expand keep open close expand keep open close synergy pharmaceuticals inc nasdaq sgyp go set alerts find a broker join td ameritrade market index overview profile news charts financials historical quotes analyst estimates options sec filings insiders marketstatecountryus synergy pharmaceuticals inc market open  real time quotes jul    pm sgyp quoteszigmancomposite   change   volume volume m real time quotes quoteszigmancomposite previous close     change   day low day high    week low  week high   company description synergy pharmaceuticals inc is a biopharmaceutical company which focuses on the development and commercialization of novel gastrointestinal therapies its product includes plecanatide and dolcanatide the company was founded by kunwar shailubhai on november   and is headquartered in new yo synergy pharmaceuticals inc is a biopharmaceutical company which focuses on the development and commercialization of novel gastrointestinal therapies its product includes plecanatide and dolcanatide the company was founded by kunwar shailubhai on november   and is headquartered in new york ny valuation pe current  pe ratio with extraordinary items  price to book ratio  enterprise value to ebitda  enterprise value to sales  total debt to enterprise value  efficiency income per employee  liquidity current ratio  quick ratio  cash ratio  profitability return on assets  return on total capital  return on invested capital  capital structure total debt to total equity  total debt to total capital  total debt to total assets  longterm debt to equity  longterm debt to total capital  officers and executives name age officer since title dr gary s jacob   chairman president  chief executive officer dr laura barrow   senior vice presidentclinical operations mr gary g gemignani   chief financial officer  executive vice president dr patrick h griffin   chief medical officer  executive vice president mr troy hamilton   chief commercial officer  executive vp insider actions – purchase – sale  – number of transactions  date name shares transaction value  gary s jacob chief executive officer director    acquisition at  per share   john p brancaccio director    acquisition at  per share   paulson  co inc    disposition at  per share   paulson  co inc    disposition at  per share   paulson  co inc    disposition at  per share   paulson  co inc    disposition at  per share   john p brancaccio director    disposition at  per share   john p brancaccio director    derivativenonderivative trans at  per share   john p brancaccio director    derivativenonderivative trans at  per share   paulson  co inc    disposition at  per share   bernard f denoyer senior vice president finance    disposition at  per share   bernard f denoyer senior vice president finance    derivativenonderivative trans at  per share   alan f joslyn director    disposition at  per share   alan f joslyn director    disposition at  per share   alan f joslyn director    disposition at  per share   alan f joslyn director    derivativenonderivative trans at  per share   gary s jacob chief executive officer director    derivativenonderivative trans at  per share   john p brancaccio director    acquisition at  per share  newslatestcompanyussgyp marketwatch news on sgyp synergy pharma stock sinks  after announcement of common stock offering  am feb    emma court synergy pharma stock sinks  after announcement of common stock offering  am feb    emma court synergy pharmaceuticals stock soars  premarket after positive trial results  am dec    tomi kilgore synergy pharmaceuticals surges  in premarket trade on positive latestage clinical trial results  am dec    emma court synergy pharma halted on latestage trial results  am dec    emma court in focus bulls maintain their advantage  pm april    lawrence g mcmillan auditor warnings on large company solvency reach highest level since crisis  am april    francine mckenna insiders are bullish about these stocks  pm april    insider monkey wednesday’s biggest gaining and declining stocks  pm jan    polya lesova synergys constipation drug meets key goals  am jan    marketwatchcom synergy pharma up  in premarket  am jan    steve gelsi friday’s biggest gaining and declining stocks  pm may    marketwatch synergy pharma down  in premarket trades  am may    steve gelsi newsnonmarketwatchcompanyussgyp other news on sgyp trellus management company llc buys uniti group inc shotspotter inc general electric co   pm july    gurufocuscom why ironwoods iw is refluxing into a sea of red  pm july    seeking alpha what to expect ahead of synergy pharmaceuticals inc sgyp q earnings oppenheimer’s take  pm july    smarteranalyst allergan reports positive new data on irritable bowl drug  pm july    zackscom synergy pharmaceuticals inc sgyp trulance poses enticing longterm uptake  pm july    smarteranalyst healthcare guru samuel isaly plays two key biotech stocks synergy pharmaceuticals inc sgpy gilead sciences inc gild  am june    smarteranalyst synergy pharmaceuticals inc’s sgyp cic drug set to stay in spotlight btig weighs in  pm june    smarteranalyst ironwoods future outlook and uncertainty  pm june    seeking alpha great point partners llc buys concert pharmaceuticals inc rigel pharmaceuticals inc ptc   pm june    gurufocuscom why this billionaire just bought gilead sciences synergy and valeant stock  pm june    motley fool my biggest mistake sticking with gilead too long bret jensen  am june    seeking alpha chipotle is a buy  cramers lightning round   am june    seeking alpha rodman  renshaw roots for synergy pharmaceuticals inc sgyp ahead of promising commercial trajectory for trulance  am june    smarteranalyst biotech forum daily digest  spotlight on  oncology concern verastem  am june    seeking alpha fda accepts synergys marketing application for expanded use of trulance shares ahead  premarket  am june    seeking alpha synergy pharmaceuticals oh frabjous day  pm june    seeking alpha is ironwoods growth about to slow  am june    motley fool synergy pharmaceuticals inc sgyp weekly rx’s hit a new high  pm june    smarteranalyst why synergy pharmaceuticals shares are popping  today  pm june    motley fool thoughts on synergy pharmas valuation as cantor initiates at overweight  am june    benzingacom loading more headlines at a glance synergy pharmaceuticals inc  lexington avenue suite  new york new york  phone   industry pharmaceuticals sector health carelife sciences fiscal yearend  view sec filings revenue na net income m employees  annual report for sgyp newspressreleasecompanyussgyp press releases on sgyp asiapacific chronic idiopathic constipation drug market forecast   pm july    pr newswire  prf global chronic idiopathic constipation drug market forecast   pm july    pr newswire  prf north america chronic idiopathic constipation drug market forecast   pm july    pr newswire  prf europe chronic idiopathic constipation drug market forecast   pm july    pr newswire  prf breakfast technical briefing on drug makers stocks  synergy pharma novo nordisk pernix therapeutics and depomed  am july    pr newswire  prf synergy pharmaceuticals announces acceptance of supplemental new drug application snda for trulance™ plecanatide for the treatment of adults with irritable bowel syndrome with constipation ibsc  am june    businesswire  bzx todays research reports on stocks to watch synergy pharmaceuticals and bioscrip inc  am june    accesswire synergy pharmaceuticals to present at the jefferies  global healthcare conference  am may    businesswire  bzx technical reports on drug makers stocks  synergy pharma novo nordisk apricus biosciences and sucampo pharma  am may    pr newswire  prf synergy pharmaceuticals and durect corporation both sail higher on trader optimism  am may    accesswire synergy pharmaceuticals to present positive trulance™ plecanatide phase  data at digestive disease week ddw for the treatment of irritable bowel syndrome with constipation ibsc  am may    businesswire  bzx synergy presents new insights at digestive disease week ddw examining patient and physician perceptions and experiences with chronic idiopathic constipation cic  am may    businesswire  bzx synergy pharmaceuticals to present trulance™ plecanatide phase  data at digestive disease week ddw for the treatment of adults with chronic idiopathic constipation cic with moderate to very severe bloating  am may    businesswire  bzx synergy pharmaceuticals to highlight new data for trulance™ plecanatide at digestive disease week ddw  am may    businesswire  bzx synergy pharmaceuticals to present at the nd annual deutsche bank healthcare conference  am april    businesswire  bzx rasna therapeutics names dr kunwar shailubhai as new ceo  pm april    businesswire  bzx synergy pharmaceuticals appoints gary g gemignani as chief financial officer  am april    businesswire  bzx synergy pharmaceuticals announces issuance of three new patents expected to extend trulance™ plecanatide patent protection until   am april    businesswire  bzx synergy pharmaceuticals launches the poop troop the first emoji keyboard designed to support dialogue around chronic idiopathic constipation cic  am april    businesswire  bzx drug makers stocks under scanner  synergy pharma novo nordisk apricus biosciences and sucampo pharma  am april    pr newswire  prf loading more headlines trending tickers quoteszigmancomposite vuzi quoteszigmancomposite jcp quoteszigmancomposite nugt quoteszigmancomposite jnug quoteszigmancomposite tlt x powered by log in  pm edt july   marketstatecountryus new york open marketstatecountryuk london closed marketstatecountryjp tokyo closed marketstatecountryus   marketstatecountryuk   marketstatecountryjp   view all latest news newslatest ptempur sealy stock price target raised to  from  at cfra pfiat chrysler gets approval to sell diesel cars pstarbucks’ teavana stores are the latest casualty at the mall phigh times is going public through a deal with a blankcheck company — and here’s what that means pintel earnings have message for amd and nvidia ‘bring it on’ pfoxconn’s history of broken promises casts a shadow on wisconsin news ptesla’s model  will be launched with panacheand a partylater friday pall the companies in jeff bezos’s empire in one large chart pbaker hughes data show weekly us oilrig count up a third time this month pamazon’s postearnings stock selloff is the smallest in seven years peuropean stocks end at month low as ubs falls tech worries weigh psurging australian dollar makes life tough for central bankers pus weekly active oilrig count up  at  baker hughes pus total weekly active drillingrig count up  at  baker hughes pseptember wti oil trades at bbl little changed from before the rig data pwhy the sec’s crackdown could be good for initial coin offerings pmattel shares down  in friday trading pexpedia stock price target raised to  from  at ubs paarons shares up  in friday trading pwhere healthcare reform goes after failure to repeal and replace obamacare loading more headlines dow quoteszigmanrealtime    nasdaq quoteszigmanrealtime    sp  quoteszigmanrealtime    kiosk   the retirementors retirement advice from our industry experts our team of financial professionals can help you plan and save for retirement then live well in it congakioskretirementorshtml    alerts congakioskalertshtml    virtual stock exchange our free stockmarket game • trade your virtual portfolio in real time • talk strategies in group discussions • find or create a game that suits you • use our learning center to improve congakioskgameshtml    location scouts housingmarket insights from our realty pros plus the latest data from realtorcom on  home markets across the us • see our complete real estate site congakioskrealestatehtml    lazy portfolios set it and forget it check out the returns on our  lazy portfolios that are made up of lowcost buyandhold index funds • how to create your own lazy portfolio congakiosklazyportfoliohtml  marketwatchcom site index topics help feedback newsroom roster media archive premium products mobile company info code of conduct corrections advertising media kit advertise locally reprints  licensing broker center your ad choices follow marketwatch rss podcasts wsjcom barrons online bigcharts virtual stock exchange financial news london wsjcom small business realtorcom mansion global copyright   marketwatch inc all rights reserved by using this site you agree to the terms of service privacy policy and cookie policy intraday data provided by six financial information and subject to terms of use historical and current endofday data provided by six financial information all quotes are in local exchange time realtime last sale data for us stock quotes reflect trades reported through nasdaq only intraday data delayed at least  minutes or per exchange requirements marketwatch top stories link to marketwatchs slice  microsoft personalized ad preferences to opt out of personalized ads in this browser your browser history must allow firstparty and thirdparty cookies and you must have your browsing experience set to not delete browsing history on exit instructions for enabling cookies and configuring your browsing history may be available in your browsers settings privacy or help documentation sign in hold on… we’re sorry but this didn’t work you can’t turn off personalized ads right now because your browser is currently blocking thirdparty cookies we can help you fix this issue let’s get started depending on what browser you use open options or settings make sure that thirdparty cookies are not blocked anymore to find out how search your browser’s help revisit httpchoicemicrosoftcomoptout and then on the “personalized ads in this browser” tile click off ext about our ads to create a more customized online experience some of the ads you may receive on microsoft websites and apps are tailored to your previous activities searches and site visits youre in control and heres where you can make the advertising choice thats right for you ext where can i learn more about advertising on microsoft websites and apps microsoft partners with oath appnexus and other third party service providers to help present customized content and display advertisements on msn outlookcom and other websites and apps microsoft also delivers search ads to bing and our search syndication partners learn more about microsoft’s privacy practices here you can learn more about interestbased ads from oath and appnexus in their privacy statements oath and appnexus what choices do i have about interestbased advertising on this page you can opt out of receiving interest based advertising from microsoft you can also opt out of receiving interestbased advertising from all selfregulatory members including microsoft oath appnexus and other third party ad networks at the following sites in the us digital advertising alliance daa in europe european interactive digital advertising alliance edaa in canada ad choices digital advertising alliance of canada daac you can control interestbased advertising in windows apps by turning off the advertising id in windows settings more choices do you want personalized ads from other companies questions if you have a privacy question or a question for the chief privacy officer of microsoft please contact us by using our web form we will respond to questions within  days ext personalized ads in this browser off optout is currently unavailable please try again later control the personalized ads setting for this web browser learn more if you want microsoft to show ads that might be relevant to you click on to show “generic” ads click off ext personalized ads wherever i use my microsoft account off sign in to change optout is currently unavailable please try again later control the personalized ads setting that applies when you are signed in on any computer or device with your microsoft account including windows windows phone xbox and other devices learn more if you want microsoft to show ads that might be relevant to you click on to show “generic” ads click off if you choose “generic” ads and use a browser your choice applies to everyone when using that browser as long as you do not clear your cookies ext personalized ads in windows in your windows settings you can turn off personalized ads that appear in apps on this device you’ll still see ads but they won’t be personalized anymore if you have windows  access the charms by touching or moving your pointer to the right edge of the screen click or tap settings and then click or tap change pc settings click or tap privacy and then turn off let apps use my advertising id for experiences across apps if you have windows  click or tap the start button click or tap settings click or tap privacy and then turn off let apps use my advertising id for experiences across apps if you have a windows mobile device go to settings tap on privacy tap on advertising id and then turn off let apps use my advertising id for experiences across apps if you want to turn off personalized ads from microsoft wherever you use your microsoft account including apps on windows windows phone xbox and other devices you can do so by selecting the microsoft account option above ext legal privacy  cookies   microsoft bing places for business bing places for business sign in using your microsoft account work account google account facebook account dont have an account create one synergy pharmaceuticals inc  new york  ny  company information products resources my account talk to a db advisor  business directory ny new york biological products except diagnostic biological products except diagnostic synergy pharmaceuticals inc s synergy pharmaceuticals inc claim this business  lexington ave rm  new york ny  get directions   wwwsynergypharmacom business info founded  incorporated annual revenue  employee count  industries biological products except diagnostic contacts donald picker contact business your email address subject message send message company summary synergy pharmaceuticals inc is located at  lexington ave rm  in new york and has been in the business of biological products except diagnostic since  verified status unverified address unverified last verified  phone unverified payment method unverified view full report similar businesses nearby our similar businesses nearby shows similar businesses in their industry and region based on information found in their dun  bradstreet credibility review profile competitive landscape our competitive landscape shows how this business compares to similar businesses in their industry and region based on information found in their dun  bradstreet credibility review profile payments accepted no data hours sunday   monday   tuesday   wednesday   thursday   friday   saturday   s view additional data select from over  networks below to view available data about this business if this data is unavailable or inaccurate and you own or represent this business click here for more information on how you may be able to correct it credibility review google facebookcom yellowbookcom bingcom yellowpagescom merchantcircle tele atlas tomtom twittercom aol mapquest yahoo local applesiri groupon hotfrogcom comcastnet search reachlocal admedia dealsplus shoptopiacom alteryx dogtime media kslcom sirtune americantownscom driverside kudzucom specialsagentcom answerscom egood lawinfocom spotlikescom anywhocom egumball likenesscom spotzot eservicelog mapmyrun technocom apartmentguidecom ezlocalcom eztousecom teleroute aroundmecom metropolistcom therapistscom atlanta newhomes findlawcom time out new york avantar findthebestcom mojopagescom bb yellowpages fivestar software mycitywaycom tripadvisor bckyrdcom giftcardscom mycouponscom beachcaliforniacom golocalcom mymovecom upmesocialcom belo goodinfo newsgazette nokia usdirectorycom carscom nomao centzycom hibu openlistcom chacha search homeplatecom ownlocalcom visikard challamacom homestore patchcom voltari citybot pelopidas vouchd classifiedads hostway placeiq walkscorecom cloudmade hoodoyou planetdiscovercom weddingwirecom powerprofiles where inc contractorscom igolocalcom radiate media wikiocity couponmap indeedcom wimgocom crowdspot innova electronics intellistrand realtorcom datasphere inthemocom replycom yellowbotcom jiwire rocket fuel yellowpagecitycom dmvorg justclicklocalcom dirxion keencom zidstercom photos business credit report receive a onetime comprehensive credit report on this company get full credit report facebook twitter yelp call  to speak with a db advisor today customer resources products education center business articles  insights glossary contact us customer support communication preferences search for db duns our company about us company history business credit history careers press releases news success stories hoovers our network partners affiliates blog access to capital entrepreneurial initiative db international supplieredge site links business directory site map pipeda privacy policy website terms of service product license agreement  dun  bradstreet inc  all rights reserved synergy pharmaceuticals inc  relationship science news home advertising board and executive moves energy health care hedge funds m  a private equity technology you have    free profiles   left this month    start your free trial ➤ hey we noticed youre a relsci pro subscriber would you like to view the page there view on relsci pro ➤ email linkedin facebook google tweet reddit permalink synergy pharmaceuticals inc overview in the news executives  employees board of directors paths owners  shareholders insider transactions recent transactions transaction advisors advisors  consultants financials competitors synergy pharmaceuticals inc overview date founded  headquarters  lexington avenue suite  new york ny  usa type of company public employees worldwide  industries pharmaceuticals it consulting  services medical support services biotechnology company description synergy pharmaceuticals inc is a biopharmaceutical company which focuses on the development and commercialization of novel gastrointestinal therapies its product includes plecanatide and dolcanatide the company was founded by kunwar shailubhai on november   and is headquartered in new york ny website httpsynergypharmacom in the news see more relsci july   pam cebulski is now serving in a new position at synergy pharmaceuticals inc pr newswire july   breakfast technical briefing on drug makers stocks  synergy pharma novo nordisk pernix therapeutics and depomed business wire june   synergy pharmaceuticals announces acceptance of supplemental new drug application snda for trulancetm plecanatide for the treatment of adults with irritable bowel syndrome with constipation ibsc business wire may   synergy pharmaceuticals to present at the jefferies  global healthcare conference pr newswire may   technical reports on drug makers stocks  synergy pharma novo nordisk apricus biosciences and sucampo pharma see full news coverage and complete stories with relsci professional create your news feed see more executives  employees gary s jacob president chief executive officer  chairman of the board gary g gemignani executive vice president  chief financial officer troy hamilton executive vice president  chief commercial officer patrick h griffin chief medical officer  executive vice president marino garcia executive vice president  chief strategy officer stephen comiskey senior directorproduct development laura barrow senior vice president clinical operations paul f c eng senior vice president drug development leslie m magnus senior vice president medical affairs pam cebulski senior vice president marketing see our list of current and previous employees when you upgrade start my free trial ➤ see more board of directors gary s jacob president chief executive officer  chairman of the board at synergy pharmaceuticals inc mel spigelman president  chief executive officer at global alliance for tb drug development john p brancaccio chief financial officer at accelerated technologies inc alan joslyn president  chief executive officer at oragenics inc thomas h adams former chairman at trovagene inc richard j daly chairman president chief executive officer  chief financial officer at neuralstem inc see our list of current and previous board members when you upgrade start my free trial ➤ see more paths to synergy pharmaceuticals inc synergy pharmaceuticals inc you connections via relationship science synergy pharmaceuticals inc sync your contacts to see how you can connect with synergy pharmaceuticals inc start my free trial ➤ see more owners  shareholders details hidden paulson  co inc paulson  cos investment strategies are all based on the same underlying investment philosophy of capital preservation and low correlation to the broad markets the firm specializes in global merger and event arbitrage as well as financial restructuring real estate and credit opportunities involving a range of financial instruments including equity and debt securities currencies commodities fixed income products mbs and other derivative securities paulsons products are provided through collective investment vehicles including both domestic partnerships and offshore private investment companies and separately managed accounts that deploy all or a subset of the firms investment strategiesthe paulson funds investment objective is to achieve positive excess returns through trading the securities andor derivatives thereon of companies that are the subject of proposed changes in corporate structure or control such as tender offers mergers spinoffs proxy contests liquidations recapitalizations restructurings and bankruptcy reorganizations paulsons objective is to purchase these securities andor derivatives at a discount to what they believe will be their value on the consummation of the proposed event a complementary objective is to minimize exposure to the general securities markets by concentrating the portfolio on eventspecific investments which act independently of the markets in addition some of the funds seek to achieve their objective through trading the securities andor derivatives of companies that are the subject of special situations such as spinoffs litigation relative value restructurings proxy contests and postbankruptcy equities as well as distressed securities and credit related securities and derivatives gold and gold related securities andor derivatives and direct real estate and real estate related securities details hidden orbimed advisors llc orbimed advisors focuses on investments in the global healthcare industry the firm invests across the spectrum of life sciences companies from earlystage private biotechnology companies to large publiclytraded pharmaceutical companies orbimed advisors manages investments across three strategies mutual funds hedge funds and private equity funds the firm is also known to engage in shareholder activist investment strategiesorbimed advisors hedge fund strategy invests both long and short in the health sciences sector orbimed employs a global investment approach that provides a broad opportunity set and reduced volatility through diversification they take long positions primarily in smallcap and midcap companies with products with the potential for future blockbuster potentialorbimed advisors mutual funds also invest globally in health sciences companies funds under management include the eaton vance worldwide health sciences fund and the finsbury worldwide pharmaceutical trust the eaton vance worldwide health sciences fund is a publiclyoffered openend mutual fund that invests globally in biotechnology and pharmaceutical investment opportunities the finsbury worldwide pharmaceutical trust is a closedend uk investment trust which also invests globally in biotechnology and pharmaceutical investment opportunitiesthe firms private equity activities focus drug discovery drug development and medical device companies the firm invests across all stages of company development with particular emphasis on mid and laterstage private companies orbimed advisors is generally the lead investor in their portfolio companies and often takes an active role on those companies boards of directors details hidden great point partners llc great point partners seeks to achieve positive excess returns by investing in publicly traded biotechnology healthcare information technology medical device medical diagnostic and specialty pharmaceutical companies the firm focuses on creating a balanced portfolio comprised primarily of companies that are undervalued by the public markets great points hedge funds employ a bottomup researchdriven approach to investing in the securities of undervalued publiclytraded healthcare companies they target fastgrowing technology driven smallcap companies in addition great point manages private equity funds that invest in private primarily profitable lower middlemarket growing healthcare companies details hidden kingdon capital management llc kingdon capital management generally manages two investment strategies longshort equity and longshort credit both strategies emphasize liquidity and diversificationkingdons longshort equity strategy seeks to maximize riskadjusted total return emphasis is placed on both bottomup individual security selection and general topdown economic analysis the firm utilizes an internally developed asset allocation model encompassing economic technical and valuation factors to allocate each funds assets among various investments each fund invests primarily in common stocks and bonds investment selection criteria include valuation both asset and earningsbased earnings momentum and relative price momentum balance sheet strength and market liquidity are also considered in addition certain securities are evaluated through a system of targets and stop losses active management of a significant portion of each funds portfolio may be emphasized with a sensitivity to shortterm market trends and price changes in individual securities each fund may sell securities short and employ leverage when such action is deemed appropriatekingdons longshort credit strategy seeks to deliver absolute returns from a diversified portfolio of credit investments with relatively low volatility such holdings may include corporate bonds loans credit default swaps credit indices distressed highyield bankruptcy claims and convertible securities the strategy uses leverage and engages in short sales the strategy combines a solid macro framework and fundamental analysis with the credit execution and risk management experience of kingdons investment professionals details hidden armistice capital llc armistice capital llc is a hedge fund manager located in new york city see  more listings with relsci professional start my free trial ➤ see  more insider transactions details hidden gary s jacob president chief executive officer  chairman of the board details hidden john p brancaccio independent director recent transactions details hidden synergy pharmaceuticals inc issued common stock details hidden synergy pharmaceuticals inc issued common stock details hidden synergy pharmaceuticals inc purchases callisto pharmaceuticals inc details hidden synergy pharmaceuticals inc issued common stock details hidden synergy pharmaceuticals inc issued units see  more listings with relsci professional start my free trial ➤ see  more transaction advisors companies ▾ auditor bdo usa llp advised on synergy pharmaceuticals inc purchases callisto pharmaceuticals inc legal advisor sichenzia ross ference kesner llp advised on synergy pharmaceuticals inc purchases callisto pharmaceuticals inc underwriter aegis capital corporation advised on synergy pharmaceuticals inc issued common stock underwriter canaccord genuity inc advised on synergy pharmaceuticals inc issued common stock underwriter cantor fitzgerald securities advised on synergy pharmaceuticals inc issued common stock people ▾ legal advisor jeffrey j fessler advised on synergy pharmaceuticals inc purchases callisto pharmaceuticals inc senior managing director andrew f viles advised on synergy pharmaceuticals inc issued common stock underwriter brian gleason advised on synergy pharmaceuticals inc issued common stock professional danielle spangler advised on synergy pharmaceuticals inc purchases callisto pharmaceuticals inc managing director eugene rozelman advised on synergy pharmaceuticals inc issued common stock see  more listings with relsci professional start my free trial ➤ see  more advisors  consultants people ▾ advisor bernard f denoyer former chief financial officer secretary  senior vice president at contravir pharmaceuticals inc key stats and financials as of  market capitalization m total enterprise value m earnings per share  revenue  net profit m ebitda m total debt m total equity m tevnet income x debt tev x three year compounded annual growth rate of revenue  five year compounded annual growth rate of revenue  see financial details and more using relsci professional start my free trial ➤ see more competitors valeant pharmaceuticals international inc  •  pharmaceuticals  •  zug zg valeant pharmaceuticals international inc engages in the development manufacture and market of a broad range of pharmaceutical products in the areas of dermatology gastrointestinal disorders eye health neurology and branded generics it operates through the following segments the bausch  lombinternational the branded rx and the us diversified products the bausch  lombinternational segment is consist of the sale of pharmaceutical products overthecounter products and medical devices products the branded rx segment is comprised of pharmaceutical products related to the salix product portfolio dermatological product portfolio branded pharmaceutical products branded generic pharmaceutical products overthecounter products medical device products bausch  lomb products sold in canada and the oncology dentistry and health products for women the us diversified products segment is the sales in the us of pharmaceutical products overthecounter products and medical device products in the areas of neurology and certain other therapeutics classes including aesthetics and generic products in the us the company was founded on march   and is headquartered in laval canada ironwood pharmaceuticals inc  •  pharmaceuticals  •  cambridge ma at ironwood we seek to transform knowledge into medicines that make a difference for patients patients shape our business they influence our drugmaking process helping us to understand and address their unmet medical needs whether we’re creating a new medicine or tackling the equally challenging task of delivering that medicine to people around the world our employees shape our success since our founding in  each of our employees has held shares in the company being owners of ironwood means we are all careful stewards of our resources we take a datadriven approach in which we celebrate definitive answers – whether those answers support holding steady or changing course – and we challenge every program to earn its way forward our discovery and development processes have generated a product that’s approved in the united states and in the european union as well as a robust pipeline as we continue to do drugmaking well we hope to inspire the support of our shareholders and earn the right to do it again – building an enduring pharmaceutical company that understands and addresses people’s needs allergan plc  •  pharmaceuticals  •  dublin du allergan plc engages in the research development and manufacture of pharmaceutical products it operates through the following segments us specialized therapeutics us general medicine and international the us specialized therapeutics segment includes sales and expenses relating to branded products within the united states the us general medicine segment involves central nervous system gastrointestinal womens health antiinfectives and diversified brands the international segment comprises of products sold outside the united states the company was founded on in  and is headquartered in dublin ireland shire plc  •  pharmaceuticals  •  dublin du shire plc is a biopharmaceutical company the company focuses on developing and marketing innovative medicines for patients with rare diseases and other conditions it engaged in the research development licensing manufacturing marketing distribution and sale of innovative specialist medicines to meet significant unmet patient needs the companys products include adderall advate adynovate agrylin antithrombin  aralast bebulin buccolam feiba firazyr and foznol shire was founded in  and is headquartered in dublin ireland astrazeneca plc  •  pharmaceuticals  •  cambridge ca astrazeneca plc is a holding company which engages in the research development and manufacture of pharmaceutical products the company produces and commercializes medicines for gastrointestinal cardiovascular neuroscience respiratory and inflammation oncology and infectious diseases its pipeline consists of azd  medi  tagrisso bloom durvalumab selumetinib lyparza polo epanova farxiga and brilinta the company distributes its products under the following brands atacand crestor onglyza nexium entocort losec merremmeronem carbocaine citanest diprivan marcainesensorcaine astrazeneca was founded on april   and is headquartered in london the united kingdom see  more listings with relsci professional start my free trial ➤ see  more youve reached your  free profiles limit this month upgrade to relsci pro today to enjoy unlimited article views and much more start my free trial ➤ still not convinced check out our full listing of features here are you a relsci pro subscriber login to relsci pro  ➤ not a pro subscriber log in here to manage your alerts keep me signed in login  ➤ forgot your password i have read the lexisnexis terms  conditions sign me up  ➤ news  synergy pharmaceuticals inc sgyp investors careers contact us news home press releases jun   synergy pharmaceuticals announces acceptance of supplemental new  view article may   synergy pharmaceuticals to present at the jefferies  view article may   synergy pharmaceuticals reports first quarter  financial  view article view all press releases events  presentations upcoming event synergy pharmaceuticals q  financial results aug   • pm edt archived event synergy pharmaceuticals  annual meeting jun   • am edt archived event jefferies  global healthcare conference jun   • pm edt view event view all events  presentations trulance™ plecanatide  synergy pharmaceuticals inc sgyp investors careers contact us trulance™ plecanatide home research and development trulance™ plecanatide trulance™ plecanatide trulance is a oncedaily tablet approved for adults with cic and is being evaluated for ibsc with the exception of a single amino acid trulance is structurally related to uroguanylin a naturally occurring and endogenous human gi peptide uroguanylin is thought to act in a phsensitive manner targeting gcc receptors primarily in the small intestine coinciding with areas of fluid secretion trulance has a boxed warning concerning the risk of serious dehydration in pediatric patients trulance is contraindicated in patients less than  years of age in nonclinical studies in young juvenile mice administration of a single oral dose of plecanatide caused deaths due to dehydration use of trulance should be avoided in patients  years to less than  years of age the safety and efficacy of trulance™ have not been established in pediatric patients less than  years of age uroguanylin analog discovery phase  phase  phase  nda filings market trulance™ plecanatide cic discovery phase complete phase  phase complete phase  phase complete phase  phase complete nda filings phase in progress market phase not started ibsc discovery phase complete phase  phase complete phase  phase complete phase  phase complete nda filings phase in progress market phase not started for additional safety information click here for full prescribing information for medication guide click here learn more about our clinical trials for trulance here synergy pharmaceuticals inc sgypo company profile  reuterscom x edition united states africa américa latina عربي argentina brasil canada  deutschland españa france india italia  méxico россия united kingdom united states profile synergy pharmaceuticals inc sgypo related topics stocksstock screenerhealthcarebiotechnology  medical research overview news key developments people charts financials analysts research pulse sgypo on nasdaq usd pm edt change  chg   prev close  open  days high  days low  volume  avg vol  wk high  wk low  full description synergy pharmaceuticals inc incorporated on february   is a biopharmaceutical company focused on the development and commercialization of gastrointestinal gi therapies the companys product candidates include trulance plecanatide and dolcanatide the company is engaged in the discovery research and development efforts around analogs of uroguanylin for the treatment of gi diseases and disorders trulance is designed to replicate the function of uroguanylin dolcanatide is being evaluated for inflammatory bowel disease ibdtrulance is approved in the united states under the trademark name trulance for the treatment of adults with chronic idiopathic constipation cic in addition it is developing trulance for the treatment of adults with irritable bowel syndrome with constipation ibsc dolcanatide is designed to be an analog of uroguanylin with enhanced resistance to standard digestive breakdown by proteases in the intestine it has demonstrated the potential antiinflammatory role of uroguanylin and uroguanylin analogs in a number of preclinical colitis models the company has released phase ib data with dolcanatide in a doubleblind placebocontrolled fourweek study evaluating approximately  patients with mildtomoderate ulcerative colitisthe company competes with ironwood pharmaceuticals inc allergan plc takeda pharmaceuticals america inc sucampo pharmaceuticals inc astrazeneca valeant pharmaceuticals international inc and shire plc » full overview of sgypo company address synergy pharmaceuticals inc  lexington ave rm new york   ny    p f  company web links home page officers  directors name compensation gary jacob  gary gemignani  marino garcia  patrick griffin  troy hamilton  » more officers  directors synergy pharmaceuticals inc news briefsynergy pharmaceuticals reports q sales  may   briefsynergy pharmaceuticals says to present positive trulance phase  data may   briefsynergy pharmaceuticals appoints gary gemignani as chief financial officer apr   briefsynergy pharmaceuticals announces issuance of three new patents expected to extend trulance patent protection until  apr   briefsynergy pharmaceuticals reports qtrly net loss per common share  mar   » more sgypo news related topics stocksstock screenerhealthcarebiotechnology  medical research